Knowles Corp — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that Knowles Corp filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $593.20M | Feb 9, 2026 |
| FY2025 | Dec 31, 2024 | $553.50M | Feb 9, 2026 |
| FY2025 | Dec 31, 2023 | $456.80M | Feb 9, 2026 |
| FY2024 | Dec 31, 2022 | $478.80M | Feb 13, 2025 |
| FY2023 | Dec 31, 2021 | $868.10M | Feb 21, 2024 |
| FY2020 | Dec 31, 2020 | $243.20M | Feb 10, 2021 |
| FY2020 | Sep 30, 2020 | $205.80M | Feb 10, 2021 |
| FY2020 | Jun 30, 2020 | $152.20M | Feb 10, 2021 |
| FY2020 | Mar 31, 2020 | $163.10M | Feb 10, 2021 |
| FY2020 | Dec 31, 2019 | $233.90M | Feb 10, 2021 |
Revenue (Net Sales)
Net sales revenue — gross revenue less returns, allowances, and discounts. Used by many manufacturers and retailers as the primary top-line figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2017 | Dec 31, 2017 | $215.50M | Feb 20, 2018 |
| FY2017 | Sep 30, 2017 | $196.00M | Feb 20, 2018 |
| FY2017 | Jun 30, 2017 | $164.40M | Feb 20, 2018 |
| FY2017 | Mar 31, 2017 | $168.30M | Feb 20, 2018 |
| FY2017 | Dec 31, 2016 | $212.90M | Feb 20, 2018 |
| FY2017 | Sep 30, 2016 | $216.50M | Feb 20, 2018 |
| FY2017 | Jun 30, 2016 | $165.20M | Feb 20, 2018 |
| FY2017 | Mar 31, 2016 | $161.10M | Feb 20, 2018 |
| FY2016 | Dec 31, 2015 | $223.50M | Feb 21, 2017 |
| FY2016 | Sep 30, 2015 | $246.70M | Feb 21, 2017 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $256.30M | Feb 9, 2026 |
| FY2025 | Dec 31, 2024 | $234.80M | Feb 9, 2026 |
| FY2025 | Dec 31, 2023 | $203.80M | Feb 9, 2026 |
| FY2024 | Dec 31, 2022 | $227.00M | Feb 13, 2025 |
| FY2023 | Dec 31, 2021 | $359.50M | Feb 21, 2024 |
| FY2020 | Dec 31, 2020 | $92.00M | Feb 10, 2021 |
| FY2020 | Sep 30, 2020 | $75.20M | Feb 10, 2021 |
| FY2020 | Jun 30, 2020 | $47.80M | Feb 10, 2021 |
| FY2020 | Mar 31, 2020 | $56.20M | Feb 10, 2021 |
| FY2020 | Dec 31, 2019 | $89.60M | Feb 10, 2021 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $44.20M | Feb 9, 2026 |
| FY2025 | Dec 31, 2024 | ($237.80M) | Feb 9, 2026 |
| FY2025 | Dec 31, 2023 | $72.40M | Feb 9, 2026 |
| FY2024 | Dec 31, 2022 | ($430.10M) | Feb 13, 2025 |
| FY2023 | Dec 31, 2021 | $150.40M | Feb 21, 2024 |
| FY2020 | Dec 31, 2020 | $29.60M | Feb 10, 2021 |
| FY2020 | Sep 30, 2020 | $5.60M | Feb 10, 2021 |
| FY2020 | Jun 30, 2020 | ($19.50M) | Feb 10, 2021 |
| FY2020 | Mar 31, 2020 | ($9.10M) | Feb 10, 2021 |
| FY2020 | Dec 31, 2019 | $20.50M | Feb 10, 2021 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $70.30M | Feb 9, 2026 |
| FY2025 | Dec 31, 2024 | $51.80M | Feb 9, 2026 |
| FY2025 | Dec 31, 2023 | $43.40M | Feb 9, 2026 |
| FY2024 | Dec 31, 2022 | $90.80M | Feb 13, 2025 |
| FY2023 | Dec 31, 2021 | $115.80M | Feb 21, 2024 |
| FY2022 | Dec 31, 2020 | $29.20M | Feb 9, 2023 |
| FY2021 | Dec 31, 2019 | $81.20M | Feb 9, 2022 |
| FY2020 | Dec 31, 2018 | $77.80M | Feb 10, 2021 |
| FY2019 | Dec 31, 2017 | $39.90M | Feb 12, 2020 |
| FY2018 | Dec 31, 2016 | $45.00M | Feb 19, 2019 |
R&D Expense
Spending on research and development activities — developing new products, improving existing ones, or conducting basic research. High R&D relative to revenue is common in technology and pharmaceutical companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $40.20M | Feb 9, 2026 |
| FY2025 | Dec 31, 2024 | $39.50M | Feb 9, 2026 |
| FY2025 | Dec 31, 2023 | $32.40M | Feb 9, 2026 |
| FY2024 | Dec 31, 2022 | $29.30M | Feb 13, 2025 |
| FY2023 | Dec 31, 2021 | $92.80M | Feb 21, 2024 |
| FY2022 | Dec 31, 2020 | $92.90M | Feb 9, 2023 |
| FY2021 | Dec 31, 2019 | $96.80M | Feb 9, 2022 |
| FY2020 | Dec 31, 2018 | $100.60M | Feb 10, 2021 |
| FY2019 | Dec 31, 2017 | $93.40M | Feb 12, 2020 |
| FY2018 | Dec 31, 2016 | $92.00M | Feb 19, 2019 |
SG&A Expense
Selling, general, and administrative expenses — the overhead costs of running the business, including salaries, marketing, legal fees, and corporate office costs. Excludes COGS and R&D.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $142.80M | Feb 9, 2026 |
| FY2025 | Dec 31, 2024 | $142.00M | Feb 9, 2026 |
| FY2025 | Dec 31, 2023 | $125.80M | Feb 9, 2026 |
| FY2024 | Dec 31, 2022 | $106.30M | Feb 13, 2025 |
| FY2023 | Dec 31, 2021 | $146.40M | Feb 21, 2024 |
| FY2022 | Dec 31, 2020 | $131.50M | Feb 9, 2023 |
| FY2021 | Dec 31, 2019 | $145.70M | Feb 9, 2022 |
| FY2020 | Dec 31, 2018 | $142.50M | Feb 10, 2021 |
| FY2019 | Dec 31, 2017 | $126.60M | Feb 12, 2020 |
| FY2018 | Dec 31, 2016 | $149.90M | Feb 19, 2019 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $32.10M | Feb 9, 2026 |
| FY2025 | Dec 31, 2024 | $13.60M | Feb 9, 2026 |
| FY2025 | Dec 31, 2023 | $16.90M | Feb 9, 2026 |
| FY2024 | Dec 31, 2022 | $32.10M | Feb 13, 2025 |
| FY2023 | Dec 31, 2021 | $48.60M | Feb 21, 2024 |
| FY2022 | Dec 31, 2020 | $31.90M | Feb 9, 2023 |
| FY2021 | Dec 31, 2019 | $41.20M | Feb 9, 2022 |
| FY2020 | Dec 31, 2018 | $80.10M | Feb 10, 2021 |
| FY2019 | Dec 31, 2017 | $51.60M | Feb 12, 2020 |
| FY2018 | Dec 31, 2016 | $38.70M | Feb 19, 2019 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.05B | Feb 9, 2026 |
| FY2025 | Dec 31, 2024 | $1.12B | Feb 9, 2026 |
| FY2025 | Dec 31, 2023 | $1.46B | Feb 9, 2026 |
| FY2024 | Dec 31, 2022 | $1.18B | Feb 13, 2025 |
| FY2022 | Dec 31, 2021 | $1.73B | Feb 9, 2023 |
| FY2021 | Dec 31, 2020 | $1.65B | Feb 9, 2022 |
| FY2020 | Dec 31, 2019 | $1.65B | Feb 10, 2021 |
| FY2019 | Dec 31, 2018 | $1.55B | Feb 12, 2020 |
| FY2018 | Dec 31, 2017 | $1.55B | Feb 19, 2019 |
| FY2017 | Dec 31, 2016 | $1.52B | Feb 20, 2018 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $775.80M | Feb 9, 2026 |
| FY2025 | Dec 31, 2024 | $756.00M | Feb 9, 2026 |
| FY2025 | Dec 31, 2023 | $1.03B | Feb 9, 2026 |
| FY2025 | Dec 31, 2022 | $992.90M | Feb 9, 2026 |
| FY2024 | Dec 31, 2021 | $1.46B | Feb 13, 2025 |
| FY2023 | Dec 31, 2020 | $1.30B | Feb 21, 2024 |
| FY2022 | Dec 31, 2019 | $1.29B | Feb 9, 2023 |
| FY2021 | Dec 31, 2018 | $1.21B | Feb 9, 2022 |
| FY2020 | Dec 31, 2017 | $1.13B | Feb 10, 2021 |
| FY2019 | Dec 31, 2016 | $1.01B | Feb 12, 2020 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $270.30M | Feb 9, 2026 |
| FY2025 | Dec 31, 2024 | $269.80M | Feb 9, 2026 |
| FY2025 | Dec 31, 2023 | $270.50M | Feb 9, 2026 |
| FY2024 | Dec 31, 2022 | $200.90M | Feb 13, 2025 |
| FY2023 | Dec 31, 2021 | $941.30M | Feb 21, 2024 |
| FY2022 | Dec 31, 2020 | $910.00M | Feb 9, 2023 |
| FY2021 | Dec 31, 2019 | $909.90M | Feb 9, 2022 |
| FY2020 | Dec 31, 2018 | $887.90M | Feb 10, 2021 |
| FY2019 | Dec 31, 2017 | $884.90M | Feb 12, 2020 |
| FY2017 | Dec 31, 2016 | $871.60M | Feb 20, 2018 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($569.40M) | Feb 9, 2026 |
| FY2025 | Dec 31, 2024 | ($613.60M) | Feb 9, 2026 |
| FY2024 | Dec 31, 2023 | ($375.80M) | Feb 13, 2025 |
| FY2023 | Dec 31, 2022 | ($448.20M) | Feb 21, 2024 |
| FY2022 | Dec 31, 2021 | ($18.10M) | Feb 9, 2023 |
| FY2021 | Dec 31, 2020 | ($168.50M) | Feb 9, 2022 |
| FY2020 | Dec 31, 2019 | ($175.10M) | Feb 10, 2021 |
| FY2019 | Dec 31, 2018 | ($224.20M) | Feb 12, 2020 |
| FY2018 | Dec 31, 2017 | ($291.90M) | Feb 19, 2019 |
| FY2017 | Dec 31, 2016 | ($360.20M) | Feb 20, 2018 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $54.20M | Feb 9, 2026 |
| FY2025 | Dec 31, 2024 | $130.10M | Feb 9, 2026 |
| FY2024 | Dec 31, 2023 | $87.30M | Feb 13, 2025 |
| FY2023 | Dec 31, 2022 | $48.20M | Feb 21, 2024 |
| FY2022 | Dec 31, 2021 | $68.90M | Feb 9, 2023 |
| FY2021 | Dec 31, 2020 | $147.80M | Feb 9, 2022 |
| FY2020 | Dec 31, 2019 | $78.40M | Feb 10, 2021 |
| FY2019 | Dec 31, 2018 | $73.50M | Feb 12, 2020 |
| FY2019 | Dec 31, 2017 | $111.70M | Feb 12, 2020 |
| FY2019 | Dec 31, 2016 | $63.40M | Feb 12, 2020 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $114.00M | Feb 9, 2026 |
| FY2025 | Dec 31, 2024 | $202.50M | Feb 9, 2026 |
| FY2024 | Dec 31, 2023 | $271.20M | Feb 13, 2025 |
| FY2023 | Dec 31, 2022 | $45.00M | Feb 21, 2024 |
| FY2021 | Dec 31, 2021 | $70.00M | Feb 9, 2022 |
| FY2021 | Dec 31, 2020 | $165.10M | Feb 9, 2022 |
| FY2020 | Dec 31, 2019 | $156.80M | Feb 10, 2021 |
| FY2019 | Dec 31, 2018 | $158.10M | Feb 12, 2020 |
| FY2018 | Dec 31, 2017 | $192.60M | Feb 19, 2019 |
| FY2017 | Dec 31, 2016 | $298.20M | Feb 20, 2018 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 0 | Feb 9, 2026 |
| FY2025 | Dec 31, 2024 | (2) | Feb 9, 2026 |
| FY2025 | Dec 31, 2023 | 0 | Feb 9, 2026 |
| FY2024 | Dec 31, 2022 | (4) | Feb 13, 2025 |
| FY2023 | Dec 31, 2021 | 1 | Feb 21, 2024 |
| FY2020 | Dec 31, 2020 | 0 | Feb 10, 2021 |
| FY2020 | Sep 30, 2020 | 0 | Feb 10, 2021 |
| FY2020 | Jun 30, 2020 | 0 | Feb 10, 2021 |
| FY2020 | Mar 31, 2020 | 0 | Feb 10, 2021 |
| FY2020 | Dec 31, 2019 | 0 | Feb 10, 2021 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 0 | Feb 9, 2026 |
| FY2025 | Dec 31, 2024 | (2) | Feb 9, 2026 |
| FY2025 | Dec 31, 2023 | 0 | Feb 9, 2026 |
| FY2024 | Dec 31, 2022 | (4) | Feb 13, 2025 |
| FY2023 | Dec 31, 2021 | 1 | Feb 21, 2024 |
| FY2020 | Dec 31, 2020 | 0 | Feb 10, 2021 |
| FY2020 | Sep 30, 2020 | 0 | Feb 10, 2021 |
| FY2020 | Jun 30, 2020 | 0 | Feb 10, 2021 |
| FY2020 | Mar 31, 2020 | 0 | Feb 10, 2021 |
| FY2020 | Dec 31, 2019 | 0 | Feb 10, 2021 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 84.89M | Feb 9, 2026 |
| FY2025 | Dec 31, 2024 | 87.36M | Feb 9, 2026 |
| FY2024 | Dec 31, 2023 | 89.09M | Feb 13, 2025 |
| FY2023 | Dec 31, 2022 | 91.08M | Feb 21, 2024 |
| FY2022 | Dec 31, 2021 | 91.89M | Feb 9, 2023 |
| FY2021 | Dec 31, 2020 | 91.61M | Feb 9, 2022 |